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1INTRODUCTION
Anal Fissure is the most common painful condition of anal region,
characterized by vertical ulcers affecting the distal end of the anal canal. It is
more common that it affects 1 in 10 people and causes very disabling symptoms
such as severe, excruciating perianal pain and anal bleeding making the patient
to suffer both physically and mentally despite rest and adequate analgesics. Anal
fissures behave more differently in the way that they are more persistent and
relapsing than acute fissures which heal spontaneously.
Regarding the etiopathogenesis of Fissures, though the Persistent
Hypertonia of the anal sphincter is claimed to be the well-established cause.
Hence the available standard treatment options direct in relieving the spasm of
the internal anal sphincter with medical methods and surgical methods. The gold
standard treatment in the management for chronic anal fissure is Lateral Internal
Sphincterotomy with healing rates above 95%. But the need for the alternative is
always been there to overcome the surgical stress and risk of incontinence. There
are various chemicals which carry out the same job of reducing the tone of
internal sphincter through their pharmacodynamics and pharmacokinetic.
Properties, of which, Diltiazem, a calcium channel blocker with its distinct
profile of excellent healing rates and mild side effects has been used in its topical
form. Though many trials have already been done with 2 % Topical Diltiazem in
management for chronic anal fissure, less significance has been paid to its
2methodology, dosage and durability of usage which may be the reason for its
higher recurrence rate.
This study has been designed by taking all the above into consideration
and it compares the healing rates of chronic anal fissures using 2% Diltiazem as
Chemical sphincterotomy with that of the Surgical Lateral Internal
sphincterotomy (Surgical sphincterotomy) as the utmost objective. It also
compares and analyze the other secondary objectives such as recovery of Pain,
Bleeding per Rectum, risk of Incontinence and the recurrence in both
procedures.
This clinical trial has been conducted in Tirunelveli Medical College
Hospital, Tirunelveli with patients suffering from chronic Anal Fissure attending
the Surgical Outpatient Department. Ethical committee approval was obtained in
Chemical
sphincterotomy
Lateral Internal
Sphincterotomy
3well advance as per protocol.  Present Study includes 190 patients of anal fissure
treated over a period of 19 months (March 2017 to September 2018). Results has
been detailed in both descriptive and statistical point of views and simplified in
an understandable format for the viewers.
4AIM OF THE STUDY
The utmost aim of the study is to compare the effectiveness of 2%
Diltiazem (Topical Gel) with the Operative Lateral Internal Sphincterotomy in
treating the chronic anal fissure, which correlates directly with the Healing rate
of Fissure.
The secondary objectives are to compare the relief of other symptoms and
florid aspects of the treatment, as mentioned below
A. Pain Relief
B. Bleeding per Anum
C. Recovery Time
D. Anal Incontinence
E. Florid aspects of Treatment.
F. Recurrence rate
G. Work resumption time
H. Rate of Conversion
5MATERIALS AND METHODS
The study was conducted as a clinical trial at Tirunelveli Medical College
Hospital, Tirunelveli during the period between March 2017 to September 2018
SAMPLE AND SAMPLE SIZE DEFINITIONS
Population:
All patients diagnosed to have chronic anal fissure attending the Surgery
Out Patient Department (OPD) of Tirunelveli Medical College Hospital,
Tirunelveli Diagnosis was based on Clinical history, examination and
Proctoscopy.
Based on the patient’s statement on excruciating pain while defecation and
bleeding during defecation.
Clinical examination involves gentle separation of the buttocks and
examination of the anus, to look for a vertical ulcer at anoderm in the distal end
of the anal canal with or without a sentinel pile.
Inclusion criteria
Every patient between the age of 15 to 64 age presenting to the Surgical
Outpatient department with complaints of painful passage of faeces and bleeding
while passing tool for more than 6 weeks.
6Exclusion Criteria
Patients with the following associated conditions were excluded from the
study:
1. Inflammatory Bowel Disease
2. Tuberculosis
3. Hemorrhoids
4. Anal Malignancy
5. Anorectal Abscess
6. Immunocompromised patients
7. Previous history of fecal Incontinence and Anal Stenosis
8. Patient who have undergone previous anal surgeries
9. Patients with history of bleeding diathesis
10. Patients with cardiovascular diseases.
SAMPLE
From the above mentioned inclusion and exclusion criteria, samples for
the study was undertaken.
SAMPLE SIZE
In this clinical trial-Parallel Study Design involves two groups, Sample
size was calculated to be 150, having 75 in each group.
7Population
Inclusion
Exclusion
Sample
Formula:
N= Z² {P1x (1-P1) + P2x (1-P2)}/ (P1-P2)²
Z- Involves the Power and significance of alpha & beta errors Power was
kept as 90% and p value significant at 0.05.
P1- Assumed success rate in Group A P2- Assumed success rate in Group B
From the observations of various studies, 80% efficacy was with
Chemical Sphincterotomy (using 2% diltiazem) and 95% with Operative Lateral
Internal Sphincterotomy. To calculate the difference between 95% confidence
level & 80% power the minimum sample required is about 75 per group.
Based on the above calculation, sample size was calculated as 75 in each
group with total of 150 patients. But the actual sample studied is 190 which is
more than the needed volume.
Fig. 3.1 Selection of Sample.
8SAMPLING METHOD
Total 190 patients with Chronic Anal Fissure attending Surgical Out
Patient Department were grouped in the study. Patients with Odd Numbers
starting 1,3,5,7…189 were assigned to group A, who received treatment with 2%
Topical Diltiazem as outpatients and the remaining even no of patients from 2,4,
6,.190 were categorized as group B (surgical lateral internal sphincterotomy).
Patients belonging to Group B were admitted in the hospital for surgery.
9METHODOLOGY[1-10]
The Group A Patients were treated with a 2% Diltiazem gel (chemical
sphincterotomy). The patients were taught individually to apply the gel
(about a size of 1.5cm) to the anoderm twice daily for 6 consecutive
weeks with well-maintained hygiene and technique.
In the present Study the 2% Topical Diltiazem gel was used. Each tube
weighed 30g and the dosage prescribed was 1.5cm for twice a day,
measured in a small scale given with the gel. It was found that each 30g
tube on milking came up to 124.5cm length. The daily maximum
requirement per day was 1.5 x 2= 3cm, and that for 6weeks 42 days (6
weeks) was 42 x 3 =   126 cm. So on an average one tube was required for
each patient to finish the course of the treatment. The cost of each tube
was around 143 rupees, so the total cost of the treatment was 143 rupees
The patients from B group were operated (lateral internal sphincterotomy)
under spinal/general anaesthesia as inpatient in the hospital. In open
method, incision was made over and across the intersphincteric groove
and the sphincter muscles are divided after separating from the anal
mucosa. The cost of this procedure could not be measured as in our
hospital, the medical treatment is completely free of cost for them.
Both the group of patients were asked to consume diet rich in fibres,
analgesics and to undergo Sitz Bath and laxatives. the patients were
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viewed in 2nd , 4th, 6th, 8th and 10th weekends during the course of
treatment.
At every visit, details regarding the fissure healing, pain relief and any
adverse effect and the recurrence were noted.
Also, enquiry was made regarding the flatus and faecal incontinence and
was calculated based on Wexner’s score.[Table3.1]
Table 3.1 Wexner incontinence score
0 - Perfect continence; 1-7 - Good continence
8-14 Moderate incontinence 15-20 severe incontinence
Healing of the fissure was assessed visually which was defined as the complete
resolution of the fissure on examination
Visual Analogue Score was used to analyse the intensity of pain.
Every patient was supplied with a pain score chart [fig3.4]. They were asked to
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circle the level of the pain in its daily. This score was graded from 0 to 10 and
marked at one end-0 (no pain) and at the other end -10 (worst pain). 1-3 (mild
pain), 4- 7 (moderate pain), 8-10 (severe pain). Our target was to achieve a pain
score of less than 3, preferably near 0.
Fig. 3.4 Visual analogue Pain scoring chart
Bleeding per Anus was also graded into the Following
0 Nil bleeding
1 Occasional blood spotting in stools (<1/week) [Minimal]
2 Blood stained stools [Mild]
3 Frank blood in stools [Moderate]
4 Blood clots passing per rectum [Severe].
Work resumption time was calculated in weeks which was defined as the time
required by the patients to comply to daily routine work with symptomatic pain
relief
Recovery time was calculated in weeks which defined as the time taken for
complete resolution of anal fissure.
Anal Fissure was considered as recurrent if the fissure reappeared or causes
symptomatic pain at the same site after 2 months of surgery or 6 weeks’ therapy
12
of 2% topical Diltiazem.
Drop outs were those patients who quit the trial before completion of 10 weeks’
trial.
Patients belonging to Group A and who have completed 10 weeks of follow up
and found refractory to treatment were switched over to operative method and
followed up. But they were considered as Failure cases of Group A. Similarly,
group B patient’s refractory to operative treatment were switched over to
Chemical sphincterotomy with patients consent. But the data stands distinct
within Group A and B, but they were included in the Conversion Rate.
Screening Procedures :
The patients underwent clinical examination including visual & Per
Rectal and Proctoscopic Examination, and were asked to fill up a questionnaire
regarding follow up.
Chemical Surgical
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ANALYSIS
The following parameter were assessed
PRIMARY: Fissure Healing Rate
SECONDARY:
a. Recovery of Pain
b. Recovery of Bleeding per rectum
c. Recovery time
d. Risk of Anal Incontinence
e. Morbid aspects of the treatment
f. Recurrence rate
g. Work resume time
h. Conversion rate.
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POPULATION
HISTORY
CLINICAL EXAMINATION
DIAGNOSED WITH CHRONIC FISSURE IN ANO
SAMPLE SELECTION AND SAMPLING
CONSENT
INCLUSION CRITERIA
EXCLUSION CRITERIA
189 CASES DIAGNOSED & FULFILLED THE
ABOVE CRITERIA
ODD- GROUP A I EVEN- GROUP B
INTERVENTION
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INTERVENTION
GROUP A GROUPB
2%DILTIAZEM CREAM SURGICAL
SPHINCTEROTOMY
FOLLOW UP AND RECORDING OF FOLLOWING PARAMETERS
Primary : Fissure Healing Rate
Secondary: Recovery of Pain
Recovery of Bleeding per rectum
Recovery time
Risk of Anal Incontinence
Morbid aspects oftreatment
Recurrence rate
Work resume time
Conversion rate.
ANALYSIS AND
INTERPRETATION OF RESULTS
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REVIEW OF LITERATURE
The principle clinical presentation of fissure in ano is intense anal pain
during defecation, often associated with small amount of bright red bleeding
noticed in toilet pan or toilet paper. There may be perianal swelling from the skin
tag and discharge of mucus. There is often sensation of tearing during defecation
and there may be a dull aching pain in the perineum 3 to 4 hours after bowel
evacuation. Women are more commonly affected than men. In the ratio of
approximately 58% to 42% respectively. Most patients are in the third decade of
life, but fissure can occur at any age. Fissure may be exacerbated by recent
episode of constipation and straining.
It commonly occurs in women after vaginal delivery. It may occur as a
complication of severe diarrhea.
Inspection of anal region reveals a small shallow anal ulcer with a sentinel
pile and edema usually in the posterior aspect of anal region particularly men.
Out of women with fissure, 40% can occur anteriorly.
Surgical Anal Canal Anatomy
The anal canal commences at the level where the rectum passes through
the pelvic diaphragm and ends at the anal verge.
Anorectal ring
The anorectal ring marks the junction between rectum and anal canal. It is
formed by the joining of the puborectalis muscle, the deep external sphincter,
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conjoint longitudinal muscle and the highest part of the internal sphincter
The puborectalis muscle
The puborectalis muscle is a part of the funnel shaped musclopelvic
diaphragm. It maintains the angle between the anal canal and the rectum and
ends the important parts of the continent mechanism.
The external sphincter
The external sphincter forms the bulk of the anal sphincter complex.
Traditionally it has been subdivided into deep, superficial and subcutaneous
portion. Being a somatic voluntary muscle, the external sphincter is red in colour
and is innervated by pudental nerve.
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The intersphincteric plane
Between the externals sphincter laterally and the longitudinal muscle
medially, exists a potential space – the intersphincteic plane this plane is
important as it contains intersphincteric glands. The plane can be opened up
surgically to access for operations on sphincter muscle.
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Internal sphincter
The internal sphincter is a thickened 2 -5 mm. it is a distal continuation of
the circular muscle coat of the rectum which has a special property and which is
a tonic state of contraction.
The epithelium and sub epithelial structure.
The pink columnar epithelium lining the rectum extends through the
anorectal ring into the anal canal. Passing downwards into the mucus membrane
becomes cuboidal and redder in colour whereas above the anal canal it is plum
coloured. Just below the anal valve there is an abrupt albit waving transition to
stratified squamous epithelium which is parchment colour. This wavy junction
contributes the dentate line. The dentate line is most important landmark both
morphologically and surgically representing he site of fusion of proctodeum and
postallantoic gut and being the sites of crypts of Morgagni. The squamous
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epithelium lining the lower anal canal is thin and shiny and is known as the
anoderm. It differs from the true skin n that it has no epidermal appendages.
Blood supply
The blood supply of upper anal canal is constant with the bifurcation of
the main trunk of superior rectal artery with right and left main branches and
with subsequent division of the former into right and left branches determine the
sites of hemorrhoids around the anal circumference. Superior rectal artery and
inferior rectal artery
Venous drainage
The upper half of anal canal is drained by superior rectal vein, tributaries
of inferior mesenteric vein. The middle rectal vein drain into internal iliac vein.
The inferior rectal vein drains the lower part of anal canal and subcutaneous part
of anal canal.
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Anatomical
distribution
Anal canal upper
2/3rd
Anal canal lower
1/3rd
Embryological Origin Endoderm Ectoderm
Blood supply Superior Rectal artery
(Portal)
Inferior Rectal artery
(Systemic)
Lymphatics Sacral & Internal Iliac
nodes
Superficial Inguinal
nodes
Nerve supply Autonomic Plexus (Pain
Insensitive)
Inferior rectal branch of
Internal Pudendal
Nerve(Pain Sensitive)
Epithelium Columnar Stratified Squamous
Haemorrhoids Internal External
Table. 4.1 Anal Canal anatomy
Embryology [41]
Hind gut opens into the posterior part of Cloaca forming the future upper
part of Anal canal and the Ectoderm of Proctodeum (Anal Membrane)
invaginates forming Anal pit, giving rise to lower part of Anal Canal.
Subsequent degeneration of the Anal membrane establishes the continuity of the
passage.
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Fig. 4.3 Development of Anal Canal
Fig 4.4 External Sphincter components
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FISSURE IN ANO [10]
An anal fissure is a longitudinal split in the anoderm of the distal anal
canal which extends form the anal verge proximally towards but not beyond
dentate line
Classification
ACUTE fissure in ano
CHRONIC fissure in ano
ACUTE ANAL FISSURE
Acute anal fissure is defined as an occurrence of a longitudinal split or
crack more commonly in the posterior aspect coupled with pain for a period of
less than 6 weeks followed by spontaneous resolution thereafter.
CHRONIC FISSURE IN ANO
Chronic fissure is characterized by hypertrophic anal papilla internally and
a sentinel pile externally (both consequent upto attempt and healing on
breakdown). Fissure lasting more than 6 weeks.
A chronic fissure may have one or all of the following features
a) Due to the chronicity of the ulceration the internal sphincter fibres may be
exposed at the base of the ulcer.
b) A Skin Tag may be seen at the distal margin of the Fissure, called as the
24
Sentinel pile.
c) At the proximal end there is the Hypertrophied Anal Papilla
Fig 4.5 Acute and Chronic Anal Fissures
Symptoms
Severe anal pain associated with defecation followed by burning
type of pain during bowel movement. Patients describe the pain as ‘passage of
broken Glasses. Bright red bleed per anus mostly as linearstreaks.
Pathophysiology
The exact etiology of Anal fissure is yet to be established Conventionally
it has been claimed that Mechanical trauma due to defecation is the cause of
Fissure in ano, with constipation history forming only 20%
Internal Anal Sphincter Contraction has proved to be the main initiating
factor in formation and propagation of the Fissures. Initially it was thought that
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the internal sphincter contraction was the primary objective in causing fissure in
secondary to mechanic trauma. This scenario keeps on continuing as the
increased tone of the sphincters leads to further constipation and then further
again causes local trauma during passage of stool, forming a vicious cycle.
Internal sphincter hypertonia increases the resting pressure of anal canal above
90mm of Hg thereby distorting the blood flow of the anal canal as the mean
pressure of the anal canal is around 85mm of Hg out of which the posterior
midline is affected the most as it is supplied by end arteries and that these
arteries penetrate through the internal sphincter before supplying the posterior
midline. This reduction in posterior anodermal blood flow was documented by
Doppler Flow study [13, 15]. It has also been found out that pain doesn’t
increase the sphincter spasm as demonstrated by the persistent Hypertonia of the
sphincter muscles even upon applying the topical anesthesia [16]. Various
theories and studies have been put in accord to the above.
One among the studies (Lund) established that the reduced Nitric Oxide
synthesis is the reason for precipitating the Fissure by increasing the Sphincter
Tone. Fissures are ischemic ulcers with the combination of raised resting tone of
Internal anal sphincter and reduced Anodermal blood supply (Schouten et al
study) at the Midline commonly. And of which the Posterior Midline is the most
poorly perfused area of the anal canal accounting for about 90% of Anal
Fissures. Anterior fissure accounts for less than 10% and 2% of them shall have
both Anterior and Posterior Fissures. Fissures occurring off the midline must
26
raise thought on its etiology. They may arise due to Infective (Sexually
transmitted infections, AIDS) or Inflammatory (Crohn’s disease, Ulcerative
Colitis) or malignancy.
Hence most modalities of management focus on relaxing the Internal anal
sphincter spasm. This is because increased tone of Internal Anal sphincter
remains the centre in vicious cycle of fissure propagation and perpetuation.
Management ranges from topical ointments to surgical sphincterotomies. And
the other modes used in the management are the stool softeners, Laxatives, sitz
bath and topical analgesics which give symptomatic relief.
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SURGICAL
Lord’s Manual Dilatation
Lords anal dilatation was described during 1838[26] and was popularly
used in the hemorrhoids surgery. The underlying principle was that under
Anaesthesia mechanical pressure is applied to internal sphincter to stretch the
fibres and release the spasm. Initially it was done using 8 fingers but now it is
done gently with 4 finger technique [28]. Nielsen Et al using endoanal
ultrasound showed that the dilatation leaded to irregular tears to both internal &
external anal sphincters causing faecal incontinence with incontinence rate of
24.3% [32].
Fig 4.6 LORD’S ANAL DILATATION
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Pneumatic Balloon Dilatation
To stabilize the procedure of anal dilatation, dilatation was done with the
Parks retractor opening up to 4.8cm with a 40mm recto sigmoid balloon. As seen
in Lords, here pneumatic Balloon pressure is used to stretch the sphincter with
slightly lower incidence of faecal incontinence [29].
Fig 4.7 Pneumatic Rectal Dilator.
Fissurectomy
Surgical technique involves simple excision of the Fissure along with the
skin tag. The resultant raw area   can be left open or is closed with various
options such as primary suturing, Y- V advancement flaps etc. Key hole
deformity occurs if the raw area is left opened.
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Anorectal Advancement Flap
Key hole deformity if occurred can be reduced by placing an Y-V
Advanceent flap.
Fig 4.8 Y- V Advancement Flap Used In Fissure Healing
SPHINCTEROTOMY [17,18,19,20,24,25]
Posterior Sphincterotomy
Introduced by Eisenheimer in 1951, it involves the division of the Internal
anal sphincter fibres at Posterior midline up to the Dentate line. It has now been
replaced by the Lateral Sphincterotomy due to the adverse effects such as
Keyhole defect and frequent Faecal soiling.
Lateral Sphincterotomy
It is the Gold standard in the treatment care of fissure in ano with over
96% cure rates. This method was re - published by Eisenheimer in 1951 and was
modified by Notaras (1969). It involves division of the Internal sphincter along
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the 3/9 ‘o’clock positions having better cure rates and reduced Incontinence
(<10%). The two methods described are, the Open and Closed Methods. In Open
method incision is made directly across the intersphincteric groove and the
sphincter muscles are divided after separating from anal mucosa. Closed
technique is a Subcutaneous technique starting with a small incision at the
intersphincteric groove then inserting a scalpel with the blade parallel to the
internal sphincter, advancing it along the intersphincteric groove and rotating
towards the internal sphincter and dividing it.
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Fig 4.10 Closed Lateral Sphincterotomy in steps.
Fig 4.9 Open Lateral Sphincterotomy
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MEDICAL MANAGEMENT
Conservative management are usually used as the first line of therapy for
Fissure in ano. It includes management ranging from High fibre diet, stool
softeners, Warm sitz bath, topical Analgesics & Chemical Sphincterotomies. All
are aimed at preventing constipation & hard stool movements, reducing the pain
& the tone of the Internal Sphincter.
I. Chemical cauterization:
This is done by using silver nitrate or phenol-in-glycerine, which takes 4
to 8 weeks for healing of ulcer.
Drawbacks:
The toxicity of the drugs, accidental injection in the surrounding tissue
amounts to general poisoning, hematoma and infection had refrain the surgeons
from resorting to this  method.
II. Chemical sphincterotomy using Nitric Oxide Donors:[38-40]
Nitric oxide is an important neurotransmitter of Non adrenergic – Non
cholinergic nerve endings of gut mediating internal anal sphincter relaxation. It
has been proved that chronic anal fissure is ischemic in origin due to poor blood
supply and spasm of internal anal sphincter. Glyceryl trinitrate and other nitrates
have a well-established role in healing of fissure by reducing the tone of internal
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sphincter. A 2% GTN gel applied twice to the anoderm for 6 weeks have given a
success rate of 68% on an average [43].
Drawbacks-
However, during the course of therapy, strict dietary restrictions to
smoothen the stool are necessary. The major drawback is headache which
amounts to 20 – 100% during the course of treatment. Despite have a good
healing rate it has also got a recurrence rate.
III. Injection of Botulinum Toxin [52-59]
Botulinum toxins A, B, and E specifically cleave SNARE Proteins,
preventing "neurosecretory vesicles" from docking/fusing with the interior
surface of the plasma membrane of the nerve synapse, and so blocks the release
of neurotransmitter. By inhibiting acetylcholine release, nerve impulses are
blocked, causing the flaccid (sagging) paralysis of muscles. A 20 Units of type A
botulinum toxin [Botox] is injected bilaterally (10 units each side) to the fissure.
The toxin exerts its effects on the acetylcholine releasing presynaptic
parasympathetic peripheral nerve endings as well as the ganglionic nerve
endings, thereby leading to flaccid paralysis of the internal sphincter.
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Fig4.12 Mechanism of Botulinium toxin
This causes sphincter paresis for about 3 months, which is sufficient for healing
of a chronic non-complicated. It is well tolerated and can be administered on an
outpatient basis. The healing rate reported is about 69-79%.
Fig 4.11 Botox Injection
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IV. Chemical sphincterotomy with Calcium Antagonists. [60-63]
Nifedipine belongs to L-type calcium channel antagonist. L-type Calcium
channels are the principal Calcium channels in the GI smooth muscles. With the
treatment of anal fissures, 20 mg of Nifedipine is given twice daily. Nifedipine is
found effective in relieving the sphincter spasm there by allowing faster healing.
Drawback:
The major drawback of this management is reduced half-life and hence
warranting frequent application of drugs and reduced sphincterolysis. Similarly,
side effects like headache, palpitations, flushing, dizziness, colicky abdominal
pain; ankle oedema, hyposmia and hypoguesia, nausea and diplopia have been
reported
Chemical Sphincterotomy with Diltiazem:
Diltiazem is a NonDihydropyridines (Non-DHP), a Calcium channel
blocker used in the treatment of hypertension, angina pectoris, and some types of
arrhythmia (Type IV antiarrhythmic drug). It relaxes the smooth muscles in the
walls of arteries, which dilates the arteries, allowing blood to flow more easily,
and lowers blood pressure. Diltiazem is also being used in the treatment of anal
fissures. Diltiazem can be taken orally or topically. When applied topically, it is
made into a gel form using either vaseline or Phlojel. Phlojel absorbs the
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diltiazem into the problem area better than the vaseline base. It has good short
term success rates. When used topically, it is used as 2% gel over the anoderm. It
decreases the tone of the Internal Anal sphincter and increases the blood supply
of the region, thereby augmenting the Fissure healing. These results are
comparable with Glyceryl trinitrate. These parameters have pushed to do many
trials to establish the efficacy and tolerability in comparison to other modes of
management.
Mechanism of
Action
Calcium channel blocker
Relaxes the internal anal sphincter, reducing pain
and increasing tissue blood
Preclinical Safety Preclinical topical safety with 2% Diltiazem twice daily
for 90 days
Clinical
Pharmacology
Topical has <10% systemic exposure as oral dose but
significantly greater effect on sphincter tone – i.e blood
levels do not predict activity. Low exposure = better
tolerability than oral diltiazem
Clinical Data Ten clinical trials in 453 individuals.
Similar or better reduction in pain, significantly better
tolerability than GTN
Table. 4.2 Topical Diltiazem in Chemical Sphincterotomy.
Several trails have been carried out to compare the efficacy and morbidity
of 2% topical Diltiazem in the management of chronic fissure in ano. Recent
studies conclude that it could be used as a first line of medical management and
surgery could be reserved for non-responders.
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In Rithin Suvarna et al trial, 2012(JCDR/2012/4386:000) they compared
the Diltiazem 2% topical ointment with that of the gold standard, Surgical
Internal Sphincterotomy. It was a prospective trial with 100 patients in each
group. The end result was that complete fissure healing was found better in
surgical (95.87%) than the chemical group (69.23%). And also recurrence rate
was 10.43% with Chemical Sphincterotomy but was nil with surgery. But
chemical method had very little incidence of anal incontinence. This trial
recommends the use of 2% Diltiazem as first line of treatment in chronic
fissures. In Majid Aziz et al trial (Journal of Surgery Pakistan (International) 17
(1) January - March 2012) involving total of 60 patients with 30 in each group,
showed that the healing rate of 2% diltiazem (33.33%) was very less compared
to that of Lateral internal sphincterotomy(96.66%.) not favoring the use of
chemical sphincterotomy.
In Giridhar C. M et al trial (J Clin Diagn Res. 2014 Oct; 8(10): NC01–
NC02.) again compared the chemical with surgical sphincterotomy. The healing
rates with 2% diltiazem was reported to better with 88.46% with mean healing
time of 5.04 weeks. Concluding that the chemical sphincterotomy must be the
first line of management of anal fissure.
In another study by Rithin Suvarna et al, 2%topical diltiazem was
compared with that of 0.2% topical glyceryl trinitrate(GTN) in the management
of chronic fissure in ano. Healing rate with topical Diltiazem (71.87%) was
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better than GTN (68.23%) with p value of 0.0001, making it statistically
significant. Also the major adverse effect was headache in both groups but with
much lesser incidence in Diltiazem group (5.2% vs. 67%). Recurrence rate was
also low in Diltiazem group (9.67% vs. 19.56%) suggesting that the chemical
sphincterotomy was a better chemical agent with higher efficacy and lesser
morbidity.
With the resources available, it can be concluded that chemical
sphincterotomy must form the initial mode of management thereby reducing the
hospital stay and avoiding the complications of surgery. Among the medical
management, Chemical sphincterotomy using topical 2% Diltiazem has been
considered to be the safest, simple, cost effective, efficacious method. Hence
2% topical Diltiazem can be used as the first line of management of chronic
fissures leaving surgical sphincteromy reserved for only the non- responders.
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STATISTICAL ANALYSIS
STUDY DEMOGRAPHY
The study involved 190 patients diagnosed with Chronic fissure in ano
attending the Surgery OPD, Tirunelveli Medical College Hospital, Tirunelveli.
Of which 7 were dropouts, who lost follow-up during the study period.
Excluding the dropouts, the final sample was 183 patients with 90 in Group A
and 93 in Group B.
AGE DISTRIBUTION
Age distribution of the Sample population ranged from 15 to 64 years,
with an average age of 37 years.
Figure 5.1 Age Distribution of The Sample
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GENDER RATIO
Females outnumbered the male subjects with the ratio of 4:5 in the study
which included 83 Males and 100 females.
Figure 5.2 Gender Proportion CHRONIC FISSURE IN ANO
Patients presenting with chronic fissure in ano with bleeding per anum and
pain were included in this study.
Chronic Anal fissure were further classified according to their site of location
into
ANTERIOR (7%)
POSTERIOR (Most Common 91.25%)
ANTERIOR + POSTERIOR (1.64%)
GENDER PROPORTION
45.40%
54.60%
MALES
FEMALES
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Figure 5.3 Locations of Chronic Anal Fissures.
LOCATION OF FISSURES
1.60% 7.10%
ANTERIOR
POSTERIOR
91.25% ANTERIOR &POSTERIOR
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ANALYSIS OF GROUP A – (Chemical Sphincterotomy)
In group A, 90 patients were treated with the Topical application of 2%
Diltiazem gel twice daily for 6 consecutive weeks.
FISSURE HEALING
Healing of fissure in ano was complete only by the 4th week and the final
cure rate was 84.4 %( 76/90) at the 10th week.
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FISSURE HEALING RATE
Table 5.1 Fissure Healing Rate in Chemical sphincterotomy.
FISSURE HEALING RATE
84.40%
77.78% 84.4%
42.00%
FISSURE HEALING
RATE
0
weeks
Figure 5.4 Fissure Healing Rate In Chemical Sphincterotomy.
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Table 5.2 Average Pain Score In Group A
MEAN PAIN SCORE
10
8
6
7.66
4
2
0
3.93 3.41 2.81 2.36
2.24
INITIAL 2nd week 4th week 6th week 8th week 10th week
AVG PAIN
AVERAGE RECOVERY TIME
The time taken for complete healing of fissure, on an average was about
5.18 Weeks in Group A.
PAIN RELIEF
The initial pain score was 7.66 in Group A and the response to treatment
in the form of immediate pain relief was achieved early in the treatment, right
from the 2nd week itself. Pain score dropped from 7.66 to 3.93 which occurred in
first 2 weeks of treatment wherein the pain was nearly halved in first 2 weeks,
allowing the patients to resume their work sooner. Pain score of 3 and lesser than
3 (Mild) was considered to be target and was achieved by 6th week.
INITIAL 2nd week 4th week 6th week 8th week 10thweek
7.66 3.93 3.41 2.81 2.36 2.24
Figure 5.5 Mean Pain Score In Group A
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BLEEDING PR RECOVERY
Table 5.3 Recovery of Bleeding Per Rectum
100
90
BLEEDING PR RECOVERY RATE
11 11 11 1180 23
70
60
50 NON- RESPONDERS
RESPONDERS
40 79 79 79 79
30 67
20
10
0
2nd Wk 4thWk 6thWk 8thWk 10th wk
RECOVERY OF BLEEDING PER ANUM
The most discomfort symptom of the patients - Bleeding per Anum was
cured faster than the Pain Relief. About 75% of patients were freed of this
discomforting symptom in first 2 weeks and by 10th week, 87.78% of patients
were cured of this symptom.
2nd Wk 4thWk 6thWk 8thWk 10thWk
67 (74.4%) 79 (87.78%) 79 (87.78%) 79 (87.78%) 79 (87.78%)
Figure 5.6 Bleeding Per Anum Recovery Rate
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WORK RESUME TIME
Work resumuption time correlated directly with the relief of both Pain and
Bleeding per anum which was about 3.37 Weeks in Group A. In other words,
patients in group A resumed their day to day productive life in 3.37 weeks on an
average.
MORBIDITY OF TREATMENT
Among the Group A involving the chemical Sphincterotomy using 2%
Topical Diltiazem, the major adverse effects were Headache and Itching. The
incidence of itching and headache were 15.6% and 6.7% respectively. The
incidence of anal incontinence was very low which were only 2 out of 90
patients (2.22%) and was temporary
Figure 5.7 Morbidity of Chemical Sphincterotmy
MORBIDITY
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RECURRENCE & CONVERSION RATE
The Recurrence rate in group A was 6.67% which was 6 patients
developed Fissures at the same site after complete healing of the Fissure within 2
months past the treatment.
Patients who didn’t respond to chemical methods and those who had
recurrences shifted the standard surgical Sphincterotmy. There were 15 patients
in this category leading to the conversion rate of 16.67%.
RECURRENCE RATE CONVERSION RATE
6(6.67%) 15(16.67%)
Table 5.4 Recurrence & Conversion Rate
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FISSURE HEALING RATE-GROUP B
Table 5.5 Fissure Healing Rate in Group B
FISSURE HEALING RATE
94.62% 97.85% 97.85%
58.06% Percentage
0%
2nd Wk 4th Wk 6th Wk 8th Wk 10TH
ANALYSIS OF GROUP B - (SURGICAL SPHINCTEROTOMY)
Group B patients (Surgical Sphincterotomy) were admitted as inpatient
and were treated with the standard Surgical method of Lateral Internal
Sphincterotomy under Spinal Anaesthesia. There were 93 patients in this group
after excluding the dropouts.
FISSURE HEALING
Healing rates with the Gold Standard Surgical method was about 97.85%.
Complete resolution of fissure was at 4th week.
Figure 5.8 Fissure Healing Rates In Group B
2nd Wk 4th Wk 6th Wk 8th Wk 10th Wk
0 54 (58.06%) 88 (94.62%) 91 (97.85%) 91 (97.85%)
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AVERAGE PAIN SCORE
Table 5.6 Mean Pain Score in Group B
10
9
8
7
6
5
4
3
2
1
0
MEAN PAINSCORE
7.92
3.4
2.17
1.41 0.83
0.55
lNlTlAL 2nd week 4th week 6th week 8th week 10th week
AVERAGE PAlN SCORE
AVERAGE RECOVERY TIME
The recovery time in Group B was 4.84 weeks during which the complete
resolution of Fissure was achieved.
PAIN RELIEF
Pain relief was more pronounced starting from the 2nd week and the score
less than 3 was achieved by 4th week itself. The final Pain score was 0.55
indicating complete pain relief in the patients.
Initial 2nd week 4th week 6th week 8th week 10th week
7.92 3.4 2.17 1.41 0.83 0.55
Figure 5.9 Pain Relief Rate in Group B
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BLEEDING PR RECOVERY
Table 5.7 Recovery of Bleeding Per Anum In Group B
100 BLEEDINGPRRECOVERYRATE
90 4 1 1 1
80 30
70
60
50
40
89 92 92 92 NON RESPONDERS
RECOVERED
30 63
20
10
0
2nd Wk 4thWk 6thWk 8thWk 10thWk
BLEEDING PR RECOVERY
RECOVERY OF BLEEDING PER ANUM
Bleeding per anum was relieved in 68% of patients by second week and
by 10th week, 98.92% of patients were relieved from bleeding per anum.
2nd Wk 4thWk 6thWk 8thWk 10thWk
63 (67.74%) 89 (95.7%) 92 (98.92%) 92 (98.92%) 92 (98.92%)
Figure 5.10 Recovery of Bleeding Per Anum In Group B
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MORBIDITY
40
27
21
3
MORBIDITY
WORK RESUME TIME
Patients resumed their normal routine work by 3.19 weeks on an average
in Group B after undergoing the operative procedure.
MORBIDITY OF TREATMENT
Immediate post-surgical complications included
Post-operative Pain,
Bleeding from Sphincterotomy site,
surgical site Infection and Faecal Incontinence.
Figure 5.11 Morbidity of Surgical Sphincterotomy In Group B
POST-OP PAIN POST-OP SURGICAL SITE FAECAL
BLEEDING INFECTION INCONTINENCE
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MORBIDITY PATIENTS PERCENTAGE
Post-OP pain 40 43.01%
Post-OP bleeding 21 22.58%
Surgical Site Infection 3 3.23%
Faecal Incontinence 27 29.03%
Table 5.8 Morbidity of Surgical Sphincterotomy
Faecal Incontinence was the most devastating problem among the post-
surgical patients, which was temporary in 88.89% cases and among the affected
27 patients, 24 had recovered from the problem in 10 weeks and 3 patients had
permanent Faecal incontinence.
RECURRENCE AND CONVERSION RATE
In Group B involving the Surgical sphincterotomy method there was nil
recurrence and the conversion rate was 2.15% (2 out of 93), proving the
reliability of this Gold Standard method.
RECURRENCE RATE CONVERSION RATE
0 2(2.15%)
Table 5.9 Recurrences and Conversion In Group B
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STATISTICAL COMPARISON OF BOTH GROUP A & B
Statistical analysis
In the study, the statistical methods were, for quantitative data, descriptive
statistics was presented by Normal, Mean, Standard Deviation and Range. For
qualitative data, frequency count N and percentage were displayed in a tabular
manner.
To analyze the data, an appropriate statistical tests were applied which
compares the two groups Independent Samples Test- t test for Equality of Means
by using statistical software SPSS (version 16.0) and Other data displayed by
various tables and charts by using Microsoft excel (windows 2010).
*Significant at p < 0.05
** very significant p <0.01
*** highly significant p < 0.001, *** highly significant p < 0.000
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Independent Samples Test
t-test for Equality of Means 95% C I of theDifference
PARAMETERS MeanDifference t df p value
Std. Error
Difference Lower Upper
lNlTlAL PAlN -0.18 -1.441 181 0.151 0.125 -0.427 0.067
PAlN SCORE
2ndweek 0.546 2.42 181 0.016* 0.226 0.101 0.992
PAlN SCORE
4thweek 1.239 5.494 181 0.0001*** 0.226 0.794 1.684
PAlN SCORE
6thweek 1.413 5.694 181 0.0001*** 0.248 0.923 1.903
PAlN SCORE
8thweek 1.528 6.44 181 0.0001*** 0.237 1.06 1.996
PAlN SCORE
10thweek 1.739 7.12 181 0.0001*** 0.244 1.257 2.221
BPR2ndWk -0.067 -0.997 181 0.32 0.067 -0.2 0.066
BPR4thWk 0.079 1.963 181 0.051* 0.04 0 0.159
BPR6thWk 0.134 3.03 181 0.003** 0.044 0.047 0.221
BPR8thWk 0.123 3.048 181 0.003** 0.04 0.043 0.202
BPR10thWk 0.123 3.048 181 0.003** 0.04 0.043 0.202
FH4thWk -0.158 -2.158 181 0.032* 0.073 -0.303 -0.014
FH6thWk -0.168 -3.403 181 0.001** 0.05 -0.266 -0.071
FH8thWk -0.134 -3.286 181 0.001** 0.041 -0.215 -0.054
FlNAL CURE RATE -0.123 -3.093 181 0.002** 0.04 -0.201 -0.045
lNCONTlNENCE -0.268 -5.308 181 0.0001*** 0.051 -0.368 -0.168
lNC –TEMP -0.236 -4.827 181 0.0001*** 0.049 -0.332 -0.139
lNC-PERMANENT -0.033 -1.732 180 0.085 0.019 -0.07 0.005
Work Resume time 0.182 0.749 165 0.455 0.242 -0.297 0.66
RECOVERYTlME 0.391 2.06 166 0.041* 0.19 0.016 0.765
RECURRENCE 0.056 1.982 181 0.049* 0.028 0 0.112
CONVERSlON 0.16 3.896 178 0.0001*** 0.041 0.079 0.24
Table 5.10 Statistical Analysis of the Study
{Df- degree of freedom. BPR- Bleeding per rectum, FH- Fissure healing, INC- Incontinence.}
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FISSURE HEALINGRATE
Table 5.11 Comparison of Fissure Healing Rates In Group A& B
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
94.62% 97.85% 97.85%
84.40%
84.40%77.78%58.06%
42.00%
0%
2nd Wk 4th Wk
GROUPB
6thWk 8thWk 10TH
GROUPA
FISSURE HEALING RATES OF GROUP A & B
The overall healing rates were more pronounced in Group B with 97.85%
of cure rates when compared to the Group A (84.4%). Also response was quicker
in Group B starting from 4th week.
Group 2ndweek 4
th week 6th week 8th week 10th week Success Rate
A 0 38(42.2%)
70
(77.78%)
76
(84.4%)
76
(84.4%) 76(84.4%)
B 0 54(58.06%)
88
(94.62%)
91
(97.85%)
91
(97.85%)
91
(97.85%)
Figure 5.12 Comparison of Healing Rates In Group A & B
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Independent Samples Test
The p value was found to be significantly right from the 4th week (0.032*)
and the final cure rate was statistically more consistent with a p value of
0.002**. Group B patients who underwent Surgical sphincterotomy had a better
cure rate than the Group A patients with Chemical Sphincterotomy.
t-test for Equality of Means
95%
C I of the
Difference
Fissure Healing
over Weeks
Mean
Difference t df p value
Std. Error
Difference Lower Upper
4thWeek -0.158 -2.158 181 0.032* 0.073 -0.303 -0.014
6thWeek -0.168 -3.403 181 0.001** 0.05 -0.266 -0.071
8thWeek -0.134 -3.286 181 0.001** 0.041 -0.215 -0.054
Final Cure Rate
10th week -0.123 -3.093 181 0.002** 0.04 -0.201 -0.045
Table 5.12 Fissure Healing Rates- p Values
AVERAGE RECOVERY TIME
The average recovery time was shorter in Group B (4.84 Weeks) than in
Group A (5.18 Weeks). The p value 0.041* was statistically significant.
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Independent Samples Test
Table 5.13 Recovery Time Comparison
RECOVERY TIME
GROUPB 4.84
GROUPA
GROUPB
GROUPA 5.18
0 1 2 3 4 5 6 7 8 9 10
t-test for Equality of Means
95%
C I of the
Difference
Mean
Difference T df p value
Std. Error
Difference Lower Upper
RECOVERY
TIME 0.391 2.06 166 0.041 0.19 0.016 0.765
Figure 5.13 Comparison of Average Recovery Time
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Table 5.14 Mean Pain Score In Group A & B
MEAN PAIN SCORE IN GROUP A & B
7.92
7.66
4
3
2
1
0
3.93
3.4 3.41
GROUP B
GROUP A
2.81
2.17 2.36 2.24
1.41
0.83 0.55
INITIAL    2nd week 4th week 6th week 8th week 10th week
AVERAGE PAIN SCORE
PAIN RELIEF
On comparison the Pain relief was much better and quicker in Group B
compared to Group A. at the end of 4th week, the pain scale dropped below 3,
whereas it was only in the 6th week with Group A. The final pain scores were
0.55 in Group B and 2.24 in Group A concluding that the pain relief was better
in group B
Group Initial 2nd week 4th week 6th week 8th week 10th week
A 7.66 3.93 3.41 2.81 2.36 2.24
B 7.92 3.4 2.17 1.41 0.83 0.55
Figure 5.14 Comparisons Of Pain Scores In Group A And B
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Independent Samples Test
From Statistical point of view, the Pain relief was significant from the 2nd week
itself (p=0.016*) and then onwards it was very much significant (p=0.0001***),
clearly depicting that the Pain Relief in Group B was certainly better than Group
A.
t-test for Equality of Means
95%
Confidence
Interval
Pain Score Mean
Difference
t df p value Std. Error
Difference
Lower Upper
Initial Pain -0.18 -1.441 181 0.151 0.125 -0.427 0.067
2ndweek 0.546 2.42 181 0.016* 0.226 0.101 0.992
4thweek 1.239 5.494 181 0.0001*** 0.226 0.794 1.684
6thweek 1.413 5.694 181 0.0001*** 0.248 0.923 1.903
8thweek 1.528 6.44 181 0.0001*** 0.237 1.06 1.996
Table 5.15 Statistical p Value for Pain Relief RECOVERY OF
BLEEDING PER ANUM
At the end of 10th week, Bleeding per anum became nil for 87.78% of
patients in Group    A and 98.92% of patients in Group B, which correlated with
the Fissure healing rates. Recovery was actually better in Group B but appeared
to be little faster in Group A during the early course of treatment which is first
2 weeks
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120.00% RECOVERY OF BLEEDING PER ANUM
100.00% 95.70% 98.92%
87.78% 87.78%
80.00% 74.40%
60.00% A
B
40.00%
20.00%
0.00%
2nd Wk 4thWk 6thWk 8thWk 10thWk
67.74%
87.78%87.78%
98.92%98.92%
BLEEDING PR RECOVERY
Group 2nd Wk 4thWk 6thWk 8thWk 10thWk
A 67 (74.4%) 79 (87.78%) 79 (87.78%) 79 (87.78%) 79 (87.78%)
B 63 (67.74%) 89 (95.7%) 92 (98.92%) 92 (98.92%) 92 (98.92%)
Table 5.16 Comparison Of Recovery Of Bleeding Per Anum
Figure 5.15 Comparison of Recovery Of Bleeding Per Anum In Group A & B
The recovery of Bleeding per anum was statistically significant from the
4th week onwards with p value of 0.051*. In the subsequent weeks (6th,,8th &
10thweek) the p value was very significant (p=0.003**), showing that the
recovery was better in Group B.
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Independent Samples Test
t-test for Equality of Means
95%
Confidence
Interval
Pain Score
Mean
Difference t df p value
Std. Error
Difference Lower Upper
2ndWk -0.067 -0.997 181 0.32 0.067 -0.2 0.066
4thWk 0.079 1.963 181 0.051* 0.04 0 0.159
6thWk 0.134 3.03 181 0.003** 0.044 0.047 0.221
8thWk 0.123 3.048 181 0.003** 0.04 0.043 0.202
10thWk 0.123 3.048 181 0.003** 0.04 0.043 0.202
Table 5.17 Comparison Of Recovery Of Bleeding Per Anum In
Group A & B
WORK RESUME TIME
Work resuming Time was better with Group B (3.19Weeks) over Group A
(3.37 Weeks) with p value of 0.455, giving not much of statistical significance.
MORBIDITY OF TREATMENT
Each group had its own specific morbid aspects such as Headache &
Itching in Group A and Post-operative pain, Surgical site bleeding & Infection in
Group B, which could not be compared.
Faecal incontinence was the factor specially measured in both groups.
Group A patients had better continence profile than the Group B
62
FAECAL INCONTINENCE
Table 5.18 Comparison Of Faecal Incontinence
And that p value was very much significant (0.0001***),
suggesting that the incidence of Faecal incontinence in Group A was very
rare, while it was common with (Group B ) Post-surgical patients.
Independent Samples Test
Table 5.19 Faecal Incontinence Comparison p Value.
GROUP +/- TEMP PERMANENT
A 2(2.22%) 2 0
B 27(29.03%) 24(25.80%) 3(3.22%)
t-test for Equality of Means
95%
Confidence
Interval
Mean
Difference t df p value
Std. Error
Difference Lower Upper
Incontinence -0.268 -5.308 181 0.0001*** 0.051 -0.368 -0.168
63
Independent Samples Test
RECURRENCE AND CONVERSION RATE
Surgical management provided nil recurrence and its conversion rate due
to failure was only 2.15% (2/93). While in Group A, the Recurrence was 6 out of
90(6.67%) and the conversion rate was 16.67% (15 out of 90, including both
failures and recurrence cases). Statistical analysis showed that the Recurrence in
Group A was significant (p=0.049*) and the conversion rate was very much
significant (p=0.0001***).
t-test for Equality of Means 95% Confidence Interval
Mean
Difference t D f p value Std. Error
Lower
limit Upper limit
Recurrence rate 0.056 1.982 181 0.049* 0.028 0 0.112
Conversion rate 0.16 3.896 178 0.0001*** 0.041 0.079 0.24
Table 5.20 Statistical p Values of Recurrence & Conversion Rates.
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DISCUSSION
The analysis of the study between both the two groups were done and the
results were justified with literature for establishing its significance. Starting
from the primary objective of Fissure healing rates to the secondary objectives of
recovery of Pain, Bleeding Per anum, Morbidity of the treatment & Recurrence
rate were analyzed and discussed in a detailed manner.
Fissure Healing Rate [71-76]
In the present study the overall healing rates were better in Group B with
97.85% of cure rates when compared to that of the Group A (84.4%). In our
study, fissure completely resolved by 4 to 8 weeks in both the groups. But
response was quicker in Group B starting from 4thweek.
When compared with the previous similar studies in the literature the
healing rate of chemical method with 2% Topical Diltiazem were ranging from
60 to 89%. The Fissure healing rate in the present study is comparable with most
of the studies.
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Study Healing rate with Diltiazem 2%
Rithin Suvarna Et al 2012 69.23%
Giridhar C. M Et al 2014 88.4%
Ansar Latif Et al 2013 74%
Manjunath S Kotennava Et al 2012 60%
Rajan vaithyanathan Et al 2015 71%
Madhusudhan M. Et 2014 89.36%
Nelson et al. 2012 80%
Sanei et al. 2009 67%
Present study 84.4%
Table 6.1 Healing Rates with 2 % Diltiazem in Chronic Fissure in Ano.
The healing rates with Surgical method was constantly high (>95%) in all
the above trials including the present study.
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Recovery time [71-76]
The average Recovery time with Topical Diltiazem was 5.18 weeks which
is one of the lesser recovery time as compared to literature(Table6.2) and is very
close to that of the  Surgical  method(4.84 weeks in the present study).
Study Average recovery time with topical2%diltiazem
Sanei et al. 2009 7.58±2.01
Abd Elhady et al. 2009 5.1±1.13 weeks
Manjunath S Kotennavar et al
2012
7.2 weeks
Giridhar C. M et al 2014 5.04 weeks
PRESENT STUDY 5.18 weeks
Table 6.2 Average Recovery Time with 2% Topical Diltiazem
Pain Recovery [71-76]
On comparison, the Pain relief was much better and faster in Group B
compared to Group A. Pain score less than 3 was achieved in Group B by 4th
week, and in group A by 6thweek. The average pain scores were 0.55 in Group
B and 2.24 in Group A, indicating that utmost pain relief was better in Group B.
The total percentage of pain recovery was 84% in Group A, which is comparable
with the literature(Table6.3).
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Study Final PainScore
Recovery With Diltiazem
Madhusudhan M. et al
2014
- 89.4%
Rajavaithyanathan et al
2015
3.38 -
Giridhar C. M et al 2014 - 78.26%
PRESENT STUDY 2.24 84%
Table 6.3 Pain Recovery with 2 % Diltiazem
Recovery of Bleeding per Anum
The total recovery rate by the 10th week in group A was 87.78% and that
of Group B was 98.92%. Not much of the studies give data regarding the
recovery of bleeding per anum. The available literature suggests that the
recovery of bleeding per anum is one of the earliest response to the treatment
along with the Pain recovery (Table6.4). In our study the response was quicker
in both groups. The cure of bleeding per anum was achieved by 2weeks in nearly
75% patients of both Groups, which is faster as compared to that achieved by
Manjunath S Koteennavaret al.
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Study Early response time
Manjunath S Kotennavar et al 2012 3weeks
Present Study 2 weeks
Table 6.4 Recovery of Bleeding per rectum with diltiazem.
MORBIDITY OF THE TREATMENT [71-76]
I. Faecal Incontinence rate
Faecal incontinence was analyzed based on the duration and separately
classified as Temporary (<10 weeks) and Permanent (>10weeks).
The Temporary incontinence was initially calculated to be in 2.22%
patients of Group A and 29.03% patients in Group B. But, the permanent
incontinence was nil in Group A and was about in 3.22% in Group B which
correlates with the data available in the literature (Table6.5).
STUDY 2% Diltiazem SurgicalSphincterotomy
Madhusudhan M. et al 2014 Nil 2.1%
Ansar Latif et al 2013 Nil 6%
Rithin Suvarna et al 2012 Nil 9.27%
Majid Aziz et al 2009 Nil 3.33%
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Present Study Temporary-
2.22%
Permanent- Nil
Temporary-29.03%
Permanent- 3.22%
Table 6.5 Faecal Incontinence Rate in Surgical and Diltiazem Groups
II. Headache
The headache was specifically associated with Group A and its incidence
was much lower 6.7% than with that of Glyceryl trinitrate (67%) as reported by
Rithin Suvarna et al.
STUDY Incidence of Headache
Manjunath S Kotennavar et al 2012 5.71%
Rithin Suvarna et al 2012 5.49%
Present Study 6.7%
Table 6.6 Headache in Diltiazem group
III. Itching
15.6% patients of Group A experienced localized itching, which was
higher than that reported by madhusudhan M et al(4.3%).  But it was mostly
temporary which lasted few minutes after application of the Ointment.
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Study Incidence of Itching
Madhusudhan M et al 2014 4.3%
Present Study 15.6%
Table 6.7 Incidence of Itching in Diltiazem group
IV. Post-operative Pain, Surgical Site Bleeding & Infection
In Gorup B the specific drawbacks were Post-operative pain (43.01%),
Surgical site bleeding (22.58%) & Infection (3.23%).
Study Infection Rate
Rajan Vaithianathan et al 2015 4.44%
Present Study 3.23%
Table 6.8 Infection rate in Surgical group.
Recurrence Rate [71-76]
In the present study the recurrence rate in Group A (2% Diltiazem) was
6.67%, whereas it was nil with surgical method. The recurrence rate in the
current Study was much lower than that reported in the literature. The data
suggests Chemical sphincterotomy can definitively be used as an alternative to
surgery when used with proper methodology and compliance.
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Study Recurrence rate
Nelson et al. 2012 12.5%
Abd Elhady et al. 2009 65%
Samim et al. 2012 17.6%
Suvarna et al. 2012 10.43%
Cevik et al. 2011 11.1%
Study Recurrence rate
Madhusudhan M et al 2014 2.1%
Ansar Latif et al 2013 25%
Rithin Suvarna et al 2012 10.43%
Present Study 6.67%
Table 6.9 Recurrence Rate in Diltiazem Groups
The final draft drawn from these observations was that the Chemical
Sphincterotomy using 2% Diltiazem has better side effect profile and good
comparable healing rates in the treatment of symptomatic Chronic Anal Fissures.
The drawbacks that warrant patient interest are the slower response, longer
duration of treatment and more chances of recurrence. With view of all these
parameters, it could be recommended that 2% Topical Diltiazem is the best
available alternative for Surgical method in treatment of chronic fissure in ano..
And surgery can be reserved for Non-responders alone.
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SUMMARY
The current study was an interventional study which compared the
Chemical Sphincterotomy (using 2% Topical Diltiazem gel) with operative
Surgical Sphincterotomy (Lateral Internal Sphincterotomy). The sample was
selected from the population with specific Inclusion & Exclusion criteria. The
total sample size was 190 of which 7 were dropouts. So only 183 patients were
studied in this trial among which 90 belonged to Group A (Chemical
Sphincterotomy) and 93 belonged to Group B (Lateral Anal Sphincterotomy).
The following parameters were compared between the two groups.
Fissure Healing Rate
Pain Recovery Rate
Bleeding per Anum Recovery Rate
Work Resume Time
Morbidity of the Treatment
Faecal incontinence
Recovery Time
Recurrence Rate
Conversion Rate
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The study was done in Tirunelveli Medical College Hospital between
March 2017 to September 2018.
The Conclusion drawn are below Fissure Healing Rate:
The final cure rates at 10th week for both the Groups were 84.4% in
Chemical sphincterotomy and 97.85% in lateral anal sphincterotomy. The
complete resolution of Fissure was documented from 4th week in both the
Groups. The Surgical sphincterotomy had better healing than the Chemical
method which was also statistically very significant.
Pain Recovery Rate:
The pain recovery was evident from the 2nd week in both the groups with
the initial pain being halved. The final pain score by 10th week in Group A
(chemical Sphincterotomy) was 2.24, which was acceptable, whereas in Group B
(Surgical sphincterotomy) the final pain average was 0.55 (very negligible)
showing complete resolution of symptoms. The rate of recovery was also
quicker in Group B than Group A.
Bleeding Per Anum Recovery Rate:
The recovery of patients from Bleeding per anum also occurred earlier
during the treatment by 2nd week in both the groups. The final recovery rates by
10th week were 87.78% in Group A and 98.92% in Group B, which correlates
with Fissure healing rates.
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Work Resume Time:
The average work resuming time were 3.37 weeks in Group A (Chemical
Sphincterotomy) and 3.19 weeks in Group B which correlated best with the
recovery of Pain and Bleeding per anum. The work resuming time was not
statistically significant.
Recovery Time:
The recovery time shows the average Fissure Healing time. It was quicker
in group B (Surgical Sphincterotomy) with about 4.84 weeks as its average
recovery time while it was 5.18 weeks with Group A (Chemical
sphincterotomy).
Morbidity of Treatment
The drawbacks unique to their respective groups. Group A had headache
(6.7%) and itching (15.6%) as its unique side effects. Group B patients had Post-
Operative Pain (43.01%), surgical site bleeding (22.58%) and Surgical site
infections (3.23%).
Faecal incontinence
Faecal incontinence was mostly experienced by the Group B (Surgical
sphincterotomy) patients in about 29.03% of them. Whereas it was only 2.22%
in Group A Patients  (Chemical Sphincterotomy), that too only temporarily. Out
of the 27 patients only 3 had permanent incontinence.
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Recurrence Rate & Conversion Rate
There was nil recurrence in Surgical limb (Group B) re- establishing that it
is the Gold Standard in the treatment of Chronic fissure in ano. In group A
(chemical Limb) the recurrence rate was 6.67%.
The conversion rate was about 16.67% in Group A and 2.15% in group B
reflecting that failure rates were higher in Group A so that patients needed to
shift to the Gold standard treatment.
The final inference from the study was that Group B (Surgical
sphincterotomy) patients definitely had better recovery & response to the
treatment than the Group A (Chemical Sphincterotomy) patients.  The only
notable major drawback was the higher faecal incontinence rate in Group B. On
the other hand Group A patients also had significantly good recovery and
response to the Chemical sphincterotomy method with lesser morbidity.
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CONCLUSION
In present study it was observed that Chemical sphincterotomy with 2%
Topical Diltiazem in the management of Chronic anal fissure in comparison with
surgical sphincterotomy has: -
 Significant fissure healing rate
 Early recovery from bleeding per anum and pain with quicker recovery time
 Least side effect profile including risk of faecal incontinence
 Significant recurrence rate requiring surgical modality for non-responders.
 Needs proper patient education, motivation and compliance
Hence this study concludes that Chemical Sphincterotomy using 2%
Topical Diltiazem could be used as a preliminary mode of management in
treating chronic anal fissure before resorting the patients to Lateral Anal
Sphincterotomy which must be used for patients who doesn’t benefit from
Chemical Sphincterotomy.
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PROFORMA
Patient Details
Name: Age/Sex: IP/OP. NO.:
Address: Occupation: Mobile No: Complaints
Chief complaints Duration
Pain
Bleeding Per Rectum
Constipation
Pruritis
History
Nourishment Anaemic Icteric Cyanosed Clubbing Pedal
edema
Pulse B.P Temp Wt
Inspection Fissure site Number Sentinel Pile Discharge Fistulous opening
Sim’s position
Palpation Tenderness Anal Tone induration Discharge
Proctoscopy Anal mucosa Hemorrhoids Internal opening
CARDIOVASCULAR SYSTEM
RESPIRATORY SYSTEM
ABDOMEN
CENTRAL NERVOUS SYSTEM
DIAGNOSIS
Past History Yes/no Personal History
Tuberculosis Diet High/low fiber
Inflammatory Bowel Disease Fluid intake >1.5/<1 l per day
Previous Perianal surgeries Alcoholic Yes/no
Pregnancy smoker Yes/no
Cardiovascular Diseases Bowel habits Regular/ irregular
Investigations
Hb: RFT: RBS: CXR: ECG:
Management plan
High fiber diet Plenty of oral fluids Laxatives
Sitz bath
A B
Timeline Pain
score*
Bleeding PR Healing of the
Fissure
Incontinence
score**
Recurrence
2nd week
4th week
6th week
8th week
10th week
SUCCESS FAILURE RECURRENCE SWITCH OVER A B
Surgical
Sphincterotomy with
Lateral internal
sphincterotomy
Chemical
Sphincterotomy
with 2% diltiazem,
INFORMED CONENT
I, Dr.V. Dheenadhayalan Post graduate student in Department of General Surgery
conducting a dissertation work for award of MS degree in General Surgery.
The topic for the study is “A Comparative Study of Chemical Sphincterotomy
(Using 2% Diltiazem) And Lateral Internal Sphincterotomy for Chronic Fissure In
Ano.”
Objectives:
1. To assess and compare the efficacy and morbidity of topical application of 2% diltiazem
gel with that of Lateral internal sphincterotomy in patients diagnosed with chronic anal
fissure.
I, have been told in a language that I understand
( ) about the study. I have been told that this is
for a dissertation procedure, that my participation is voluntary and I he/she reserve
the full right to withdraw from the study at my own initiative at any time, without
having to give any reason, and that decision to participate or withdraw from the
study at any stage will not prejudice my/his/her, rights and welfare. Confidentiality
will be maintained and only be shared for academic purposes.
I hereby give consent to participate in the above study. I am also aware that I can
withdraw this consent at any later date, if I wish to. This consent form being signed
voluntarily indicates agreement to participate in the study, until I decide otherwise. I
understand that I will receive a signed and dated copy of this form.
I have signed this consent form, before my participation in this study.
Signature of the subject:
Date:
Place:
Signature of the witness:
Date:
Place:
I hereby state that the study procedures were explained in detail and all
questions were fully and clearly answered to the above mentioned participant
/his/her relative.
Investigators signature:
Date:
Place:
Contacts address:
NehahspfSf;F mwptpg;G kw;Wk; xg;Gjy; gbtk; (kUj;Jt Ma;tpy; gq;Nfw;gj;w;F)
Ma;T nra;ag;gLk; jiyg;G:
gq;F ngWthpd; ngaH:
gq;F ngWthpd; taJ:
gq;F ngWth;
,jid 
Fwpf;fTk;
1. ehd; NkNy Fwpg;gpl;Ls;s kUj;Jt Ma;tpd; tptuq;fis gbj;J
Ghpe;J nfhz;Nld;. vd;Dila re;Njfq;fis Nfl;fTk;> mjw;fhd
jFe;j tpsf;fq;fis ngwTk; tha;g;gspf;fg;gl;Ls;sJ vd mwpe;J
nfhz;Nld;.
2. ehd; ,t;tha;tpy; jd;dpr;irahf jhd; gq;Nfw;fpNwd;. ve;j
fhuzj;jpdhNyh ve;j fl;lj;jpYk;> ve;j rl;l rpf;fYf;Fk;
cl;glhky; ehd; ,t;tha;tpy; ,Ue;J tpyfp nfhs;syhk; vd;Wk;
mwpe;J nfhz;Nld;.
3. ,e;j Ma;T rk;ge;jkhfNth> ,ij rhHe;J NkYk; Ma;T
Nkw;fhs;Sk; NghJk; ,e;j Ma;tpy; gq;FngWk; kUj;JtH
vd;Dila kUj;Jt mwpf;iffis ghHg;gjw;F vd; mDkjp
Njitapy;iy vd mwpe;J nfhs;fpNwd;. ehd; Ma;tpy; ,Ue;J
tpyfpf; nfhz;lhYk; ,J nghUe;Jk; vd mwpfpNwd;.
4. ,e;j Ma;tpd; %yk; fpilf;Fk; jftiyNah> KbitNah
gad;gLj;jpf; nfhs;s kWf;f khl;Nld;.
5. ,e;j Ma;tpy; gq;F nfhs;s xg;Gf; nfhs;fpNwd; vdf;F
nfhLf;fg;gl;lmwpTiufspd; gb ele;J nfhs;tJld;> Ma;it
Nkw;nfhs;Sk; kUj;Jt mzpf;F cz;ikAld; ,Ug;Ngd; vd;W
cWjpaspf;fpNwd;. vd; cly; eyk; ghjpf;fg;gl;lhNyh> my;yJ
vjpHghuhj> tof;fj;jpw;F khwhd Neha;Fwp njd;gl;lhNyh clNd
,ij kUj;Jt mzpaplk; njhptpg;Ngd; vd cWjp mspf;Nwd;.
gq;Nfw;gthpd; ifnahg;gk; / ...............................................,lk;...........................................
fl;iltpuy; Nuif
gq;Nfw;gthpd; ngaH kw;Wk; tpyhrk; ......................................................................................
Ma;thshpd; ifnahg;gk; /...................................................,lk; .........................................
Ma;thshpd; ngaH ..................................................................................................................
ikak; ........................................................................................................................................
fy;tpawpT ,y;yhjtw;F (ifNuif itj;jtHfSf;F) ,J mtrpak; Njit
rhl;rpapd; ifnahg;gk; /.................................................,lk; ..............................................
ngaH kw;Wk; tpyhrk; .............................................................................................................
KEY TO MASTER CHART
FISSURE LOCATION
A-ANTERIOR P-POSTERIOR
A+P- ANTERIOR &POSTERIOR
IMMEDIATE POST PROCEDURE COMPLICATIONS P- PAIN
I- SURGICAL SITE INFECTION B-SURGICAL SITE BLEEDING IT-ITCHING
H-HEADACHE
BLEEDING PER ANUM 0-NIL
1-OCCASIONAL BLOOD SPOTTING IN STOOLS(MINIMAL)
2- BLOOD STAINED STOOLS(MILD)
3-FRANK BLOOD IN STOOLS(MODERATE)
4-BLOOD CLOTS PASSING PER RECTUM(SEVERE)
COLOR CODING
GROUP A
GROUP B
GROUP A FAILURES
GROUP B FAILURES
DROPOUTS
RECURRENCE
S. No Study No Name Age Sex Op No 2nd week 4th week 6th week 8th week 10th week
1 1 Subbulakshmi 25 F 107318
2 3 Gandinathan 26 M 149723
3 5 Mariammal 28 F 124568
4 7 Muthumari 18 F 235461 DO
5 9 Stephen Joseph 55 M 194732
6 11 Gandimathi 25 F 139741
7 13 Kalyanalakshmi 29 F 132654
8 15 Ishwariya 30 F 179211
9 17 Jayakumar 19 M 125678
10 19 Subbiah 32 M 124567
11 21 Padma 34 F 135621
12 23 Valliammal 36 F 169875
13 25 Ellupandian 16 M 145863
14 27 Jayalakshmi 28 F 124785 DO
15 29 karruppusamy 29 M 169874
16 31 Thangammal 64 F 123569
17 33 Karthik 17 M 124569
18 35 Rohini 36 F 157893
19 37 Jeenesh 55 M 136542
20 39 Annamuthu 22 F 125879
21 41 Krithika 32 F 125698
22 43 Essakiammal 56 F 125689
23 45 Gayathri 34 F 126547
24 47 Sudalaimuthu 25 M 123654
25 49 Chandra 28 F 132465
26 51 Maari 58 F 198756
27 53 Ramakrishnan 29 M 163978
28 55 Kaaliammal 24 F 145689
29 57 Essakiammal 25 F 195462
30 59 Mallika 59 F 132685
31 61 Rani 32 F 136574
32 63 kannan 17 M 132695
33 65 Vellasamy 34 M 165478
34 67 Manimegalai 62 F 165985 DO
35 69 lakshmi Devi 64 F 126475
36 71 Govindan 36 M 163254
37 73 Kalavathy 19 F 125469
38 75 Chidambarakani 38 F 132659
39 77 Petchi 39 F 123647
40 79 Rajendran 62 M 159846
41 81 Natchiyar 63 F 123652
42 83 Kupliyaandi 42 M 168745
43 85 Muthukani 44 F 136598
44 87 Rajagopal 61 M 164253
45 89 Vellamal 45 F 145623
46 91 Muthusamy 60 M 165324
47 93 Arputhamary 25 F 148659
48 95 Vadivu 46 F 136528
49 97 Muthupandi 48 M 175469
50 99 Balasurya 55 F 165234
51 101 Rajeshwari 28 F 165892
52 103 Balakrishnan 56 M 132456
53 105 Monisha 50 F 187542
54 107 Balamurugan 57 M 165234
55 109 Kaalimuthu 45 M 165289
56 111 Chelladurai 46 M 167542
57 113 Muthuraj 58 M 169857
58 115 Vijayakumar 29 M 123657 DO
59 117 Anthonyraj 24 M 156987
60 119 Karunakaran 59 M 136528
61 121 Gopalasamy 36 M 184573
62 123 Suresh 38 M 136952
63 125 Palani 62 M 245876
64 127 Paapa 36 F 136529
65 129 Periyadevar 61 M 145328
66 131 Ganeshan 39 M 169875
67 133 Ramasamy 37 M 125476
68 135 Muneeshwaran 63 M 165329
69 137 Chellapandi 19 M 156498
70 139 Paramsivam 42 M 123478
71 141 Muthuiah 45 M 159623
72 143 Jayaraj 64 M 175489
73 145 Sivalingam 44 M 163285
74 147 Kumar 46 M 169754
75 149 Muthuselvan 59 M 125478 DO
76 151 Saravanan 48 M 123578
77 153 Padmanaban 58 M 184597
78 155 Mydeen 29 M 126354
79 157 Baskar 30 M 128569
80 159 Pandian 20 M 136745
81 161 Essakiappan 32 M 132569
82 163 Muthuraj 33 M 175486
83 165 Bharanidharan 38 M 169875
84 167 Muthu 64 M 163257
85 169 Arun 29 M 185479
86 171 Chandru 26 M 123685
87 173 Kalai 33 M 175489
88 175 Bharathi 39 M 169852
89 177 Diwahar 50 M 167548
90 179 Jason 64 M 163258
91 181 Rajesh 46 M 159872
92 183 Essakimuthu 43 M 157426
93 185 Mariappan 59 M 136582
94 187 Vinoth 49 M 147865
95 189 Raju 29 M 132659


S. No Study No Name Age Sex IP No 2nd week 4th week 6th week 8th week 10th week
1 2 Naseer begam 52 F 32625
2 4 Ramasamy 26 M 30862
3 6 Indra 18 F 30788
4 8 Marimuthu 58 M 83301
5 10 Lakshmi 30 F 32521
6 12 Gajendran 59 M 32570
7 14 Thangaraj 23 M 32625
8 16 Chellammal 32 F 32550
9 18 Subbuammal 64 F 73551
10 20 Iyyappan 35 M 34547
11 22 Vadivu 17 F 35679
12 24 Thangapushpam 36 F 37451
13 26 Perrachi 35 M 38925
14 28 Thangammal 16 F 38923 DO
15 30 Tamilselvi 56 F 40729
16 32 Muthuammal 39 F 42416
17 34 Padmavathy 54 F 45476
18 36 Kumar 22 M 52553
19 38 Tamilarasi 40 F 54445
20 40 Vijayalakshmi 59 F 54419
21 42 Gurunathan 42 M 54564
22 44 Kumari 62 F 57463
23 46 Madasamy 44 M 55881
24 48 Radha 64 F 59179
25 50 Das 25 M 59274
26 52 Navinraj 26 M 64349
27 54 Fathima 28 F 74490
28 56 Nellaippan 32 M 70655
29 58 Michael 33 M 70572
30 60 George 20 M 73985
31 62 Subbulakshmi 36 F 23506
32 64 Rohit 50 M 77703
33 66 Annie 18 F 31341
34 68 Kaaliappan 45 M 21616
35 70 Sivaperumal 56 M 29839
36 72 Ganesan 49 M 35877
37 74 Poolammal 45 F 34456
38 76 Muthulakshmi 19 F 40445
39 78 Arunachalam 42 M 60655
40 80 Gnanaprakash 28 M 61635
41 82 Thirumalai 16 M 43611
42 84 Anitha 26 F 6557
43 86 Vellammal 55 F 37609
44 88 Sekar 25 M 65407
45 90 Murugeshwari 22 F 67359
46 92 Marimuthu 30 M 3682
47 94 Rubi 54 F 9006
48 96 Ganesh Kumar 24 M 4064
49 98 Saraswathi 32 F 6136
50 100 Paulraj 33 M 67090
51 102 Samuthirakani 57 F 70058
52 104 Sheik mohammed 39 M 68842
53 106 Amutha 64 F 60791
54 108 Shanmugavel 35 M 72222
55 110 Venkatesh 62 M 7371111
56 112 Selvakumar 42 M 76328
57 114 Shobana 45 F 777784
58 116 Essaki 46 M 6151
59 118 Shanmugam 48 M 7778
60 120 Mymoon Beevi 64 F 7931
61 122 Rama 46 F 67767
62 124 Vishal 48 M 12985
63 126 Kaalimuthu 47 M 16127
64 128 Selvi 63 F 16153
65 130 Roja 49 F 17966
66 132 Shankaralingam 28 M 19496
67 134 Chokanathan 29 M 19482
68 136 Vellapandi 30 M 17911
69 138 Chellathai 19 F 2274
70 140 Petchiammal 35 F 23031
71 142 Muthuraj 36 M 24140
72 144 Baseer 32 M 21226
73 146 Veerammal 31 F 24700
74 148 Essakiammal 30 F 23025
75 150 Subramani 38 M 26268
76 152 Ambika 39 F 26300
77 154 Uthira 62 F 28252
78 156 Umayun 40 M 28134
79 158 Velselvi 45 F 79243 DO
80 160 Santhoshi 23 F 28098
81 162 Muppidathy 46 F 29682
82 164 Arokiyam 61 F 29770
83 166 Arjun 45 M 31391
84 168 Divya 61 F 31466
85 170 Tamilarasan 24 M 33307
86 172 Mariyapushpam 42 F 33450
87 174 Krishnammal 64 F 32108
88 176 Amravathi 41 F 33346
89 178 Rajeshwari 35 F 37245
90 180 Thulasi 64 F 37072
91 182 Oorkali 33 F 31308
92 184 Arumugam 62 M 37320
93 186 Essakiammal 36 F 35061
94 188 Shanthammal 39 F 38819
95 190 Shanthi 61 F 38816
10th week

